A Study to Evaluate the Safety, Biodistribution, Internal Radiation Dosimetry, and Effective Dose of DaTSCAN™ Ioflupane (123I) Injection in Chinese Healthy Volunteers.
Clinical trial NCT04564092 · COMPLETED
Trial details
- NCT number
- NCT04564092
- Sponsor
- GE Healthcare
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-13
- Primary completion
- 2021-09-04
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.